1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 32272148 | Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma. | 2020 Jul 28 | 3 |